Flagship Wealth Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
Flagship Wealth Advisors's DNA Position: Q3 2026 in Review
Flagship Wealth Advisors opened a new position in Ginkgo Bioworks (DNA) in Q3 2026: 2 shares worth $26. The stake represents ﹤0.01% of the portfolio and ranks #463 among its holdings.
184 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- Flagship Wealth Advisors held 2 shares of Ginkgo Bioworks worth $26 as of Q3 2026.
- Ginkgo Bioworks was a new Flagship Wealth Advisors position in Q3 2026.
- Ginkgo Bioworks made up ﹤0.01% of Flagship Wealth Advisors's portfolio in Q3 2026, its #463 holding.
- 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on Flagship Wealth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.